About
PET Imaging, radiochemical synthesis, radiopharma probes
Areas of Focus
Categories
DiagnosticsVirginia, DC, DE & Maryland
Clinical Trials (5)
View allTotal Trials
5
As Lead Sponsor
4
As Collaborator
1
Total Enrollment
599
By Phase
PHASE3: 2PHASE2: 2
By Status
NOT_YET_RECRUITING: 3COMPLETED: 1ACTIVE_NOT_RECRUITING: 1
Clinical Trials Pipeline5 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2021
2022
2023
2024
2025
2026
2027
2028
Today
Hover over trial bars to see details
Recent Trials
NCT07077213Collaborator
18F-FAPI-74 in Tuberculosis Patients
N/ANot yet recruiting
30 participants
Started: Dec 31, 2025 · Completed: Dec 1, 2027
NCT07217717Lead Sponsor
Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Pancreatic Ductal Adenocarcinoma (PDAC)
PHASE3Not yet recruiting
200 participants
Started: Dec 15, 2025 · Completed: Dec 31, 2027
NCT07217704Lead Sponsor
Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Gastric or Esophageal Cancer.
PHASE3Not yet recruiting
200 participants
Started: Nov 12, 2025 · Completed: Aug 30, 2027
NCT05641896Lead Sponsor
Study of [18F]FAPI-74 PET in Patients With Gastrointestinal Cancers
PHASE2Completed
109 participants
Started: Apr 28, 2023 · Completed: Jul 1, 2025
NCT05262855Lead Sponsor
Study of [68Ga]FAPI-46 PET in Patients With Pancreatic Ductal Carcinoma
PHASE2Active, not recruiting
60 participants
Started: May 2, 2022 · Completed: Oct 15, 2025
Locations (1)
Headquarters
Dulles, VA, United States
Map
Loading map...